switching between glp-1 agonists GLP‐1 receptor in clinical practice: Expert consensus and practical guidance - Jain - 2021 - International Journal of Clinical Practice Switching from tirzepatide to retatrutide:

The majority of GLP-1 medications are only approved for adults 18 years and older

demonstrated expressions of GLP1 receptors in human TNBC cells and tissues from BALB/cfC3H mice bearing 4T1 tumor cell implants and tumor cell growth increased with liraglutide injection [102]

Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 Randomized Clinical Trial

Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood changes, hunger, weakness or feeling jittery

Retail Pharmacies is the fastest-growing segment in the market due to its extensive geographic reach and its position as the primary channel for dispensing medication to patients